(19)
(11) EP 2 374 450 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
17.10.2012 Bulletin 2012/42

(45) Mention of the grant of the patent:
27.06.2012 Bulletin 2012/26

(21) Application number: 10159137.8

(22) Date of filing: 06.04.2010
(51) International Patent Classification (IPC): 
A61K 31/724(2006.01)
A61K 9/20(2006.01)
A61K 45/06(2006.01)
 A61K 31/135(2006.01)
A61K 31/496(2006.01)
A61K 47/40(2006.01)

(54)

Flupentixol compositions

Flupentixolzusammensetzungen

Compositions de flupentixol

(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
AL BA ME RS

(43) Date of publication of application:
12.10.2011 Bulletin 2011/41

(73) Proprietor: H. Lundbeck A/S
2500 Valby (DK)

(72) Inventor:
  • Olsen, Flemming, Enok
    3450, Allerød (DK)


(56) References cited: : 
US-A- 5 904 929
   
  • Anonymous: "Deanxit -Dragees"[Online] March 2008 (2008-03), XP002596510 Pharmazie.com Retrieved from the Internet: URL:http://www.pharmazie.com/graphic/A/93/ 0-14693.pdf> [retrieved on 2010-08-12]
  • DATABASE WPI Week 200872 Thomson Scientific, London, GB; AN 2008-M13873 XP002596184 & CN 101 125 131 A (SHANGHAI CIRUI MEDICAL SCI CO LTD) 20 February 2008 (2008-02-20)
  • DATABASE MEDLINE [Online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; February 1979 (1979-02), ENEVER R P ET AL: "Flupenthixol dihydrochloride decomposition in aqueous solution." XP002595737 Database accession no. NLM423084 & JOURNAL OF PHARMACEUTICAL SCIENCES FEB 1979 LNKD- PUBMED:423084, vol. 68, no. 2, February 1979 (1979-02), pages 169-171, ISSN: 0022-3549
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).